Condition
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06261424Not ApplicableRecruitingPrimary
Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
NCT01793168Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT05768750Not ApplicableUnknownPrimary
A Home-based Rehabilitation in ARSACS
NCT05479656Not ApplicableCompletedPrimary
A Rehabilitation Program to Increase Balance and Mobility in Ataxia of Charlevoix-Saguenay
Showing all 4 trials